Johnson & Johnson Paying $1B For Oncology Startup Firefly
By Al Barbarino · June 8, 2026, 4:23 PM EDT
Johnson & Johnson said Monday it has agreed to acquire Firefly Bio Inc. for $1 billion in cash, adding a proprietary technology that targets hard-to-treat tumors. ...
To view the full article, register now.